Results 31 to 40 of about 30,982 (215)

COVID-19 vaccine in the Kingdom of Saudi Arabia: A true operation warp speed

Journal of Nature and Science of Medicine, 2021
As of January 2021, 1 year has passed since the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was first discovered, which is the cause of the coronavirus disease-2019 (COVID-19) pandemic that has infected almost 100 million people ...
Mazin Barry, Ahmed S BaHammam
doaj   +1 more source

Evaluation of Two-Month Antibody Levels after Heterologous ChAdOx1-S/BNT162b2 Vaccination Compared to Homologous ChAdOx1-S or BNT162b2 Vaccination [PDF]

, 2022
We evaluated the post-vaccination humoral response of three real-world cohorts. Vaccinated subjects primed with ChAdOx1-S and boosted with BNT162b2 mRNA vaccine were compared to homologous dosing (BNT162b2/BNT162b2 and ChAdOx1-S/ChAdOx1-S). Serum samples
Chiara Orlandi, Magnani, Mauro, Marcello Ceccarelli, Eugenio Carlotti, Ceccarelli, Marcello, Daniela Vandini, Carlotti, Eugenio, Orlandi, Chiara, Luca Galluzzi, Gloria Buffi, Barocci, Simone, Anna Casabianca, Galluzzi, Luca, Mauro Magnani, Rocchi, Marco Bruno Luigi, Casabianca, Anna, Aurora Diotallevi, Diotallevi, Aurora, Vandini, Daniela, Simone Barocci, Buffi, Gloria, Marco Bruno Luigi Rocchi   +21 more
core   +1 more source

Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination [PDF]

Vaccines, 2021
Anaphylactic reactions were observed after Singapore’s national coronavirus disease 2019 (COVID-19) vaccination programme started in December 2020. We report the clinical and laboratory features of three patients in our institution who developed anaphylactic reactions after receiving the Pifzer BNT162b2 vaccine.
Xin Rong Lim, Bernard Pui Leung, Carol Yee Leng Ng, Justina Wei Lynn Tan, Grace Yin Lai Chan, Chien Mei Loh, Gwendolyn Li Xuan Tan, Valerie Hui Hian Goh, Lok To Wong, Chong Rui Chua, Sze Chin Tan, Samuel Shang Ming Lee, Hwee Siew Howe, Bernard Yu Hor Thong, Khai Pang Leong   +14 more
openaire   +3 more sources

Increased neutralization of SARS-CoV-2 Delta variant after heterologous ChAdOx1 nCoV-19/BNT162b2 versus homologous BNT162b2 vaccination [PDF]

, 2022
Heterologous SARS-CoV-2 vaccine approaches with a second mRNA-based vaccine have been favored in the recommendations of many countries over homologous vector-based ChAdOx1 nCoV-19 vaccination after reports of thromboembolic events and lower efficacy of ...
Salzberger, Bernd, Peterhoff, David, Bauswein, Markus, Hiergeist, Andreas, Schmidt, Barbara, Gessner, André, Bauernfeind, Stilla, Wagner, Ralf, Plentz, Annelie   +8 more
core   +1 more source

Waning Immunity after the BNT162b2 Vaccine in Israel

New England Journal of Medicine, 2021
In December 2020, Israel began a mass vaccination campaign against coronavirus disease 2019 (Covid-19) by administering the BNT162b2 vaccine, which led to a sharp curtailing of the outbreak. After a period with almost no cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, a resurgent Covid-19 outbreak began in mid-June 2021.
Yair Goldberg, Micha Mandel, Yinon M. Bar-On, Omri Bodenheimer, Laurence Freedman, Eric J. Haas, Ron Milo, Sharon Alroy-Preis, Nachman Ash, Amit Huppert   +9 more
openaire   +2 more sources

Effectiveness of the BNT162b2 mRNA COVID-19 Vaccine in Pregnancy [PDF]

Nature Medicine, 2021
Abstract Background: As mass vaccination campaigns against COVID-19 accelerate worldwide, there remains only limited evidence regarding vaccine effectiveness (VE) among pregnant women. Pregnant women have been shown to be at risk for severe COVID-19, resulting in adverse obstetrics outcomes, and their immune system is known to undergo ...
Noa Dagan, Noam Barda, Tal Biron-Shental, Maya Makov-Assif, Calanit Key, Isaac S. Kohane, Miguel A. Hernán, Marc Lipsitch, Sonia Hernandez-Diaz, Ben Y. Reis, Ran D. Balicer   +10 more
openaire   +5 more sources

Adverse events upon BNT162b2 vaccination.

, 2022
Adverse events upon BNT162b2 vaccination.
Nicolas Escriou (17497), Georgia Giannopoulou (14149534), Eleni Ntoukaki (14149528), Abraham Pouliakis (3694663), Konstantinos Lazaridis (384402), Stavroula Labropoulou (10297409), Petros Eliadis (14149531), Eleni Gaitanarou (14149537), Gerasimina Tsinti (14149522), Peggy Lymberi (14149543), Alexios Dimitriadis (14149519), Andreas Mentis (183644), Evangelia Sotiropoulou (14149525), Marija Backovic (3087789), Avgi Mamalaki (325291), Ioannis Sarrigeorgiou (14149513), Dimitra Moschandreou (14149516), Elisavet Grouzi (14149540)   +17 more
core   +1 more source

Myopericarditis following both BNT162b2 and NVX-CoV2373

Allergy, Asthma & Clinical Immunology, 2022
Abstract Background Myopericarditis is a well reported complication associated with SARS-Cov-2 (COVID-19) infection and vaccinations; particularly with mRNA vaccines (BNT162b2 and mRNA-1273), and in the young male population.
Saima Ahmad, Chino Yuson, Adrianna Le, Pravin Hissaria   +3 more
openaire   +3 more sources

Myocarditis after BNT162b2 vaccination in a healthy male

The American Journal of Emergency Medicine, 2021
Myocarditis following mRNA COVID-19 vaccination has recently been reported to health authorities in the United States and other countries. Cases predominately occur in young adult males within four days following the second dose of either the Moderna (mRNA-1273) or Pfizer-BioNTech (BNT162b2) vaccines.
Watkins, Kevin, Griffin, Gregory, Septaric, Kristen, Simon, Erin L.   +3 more
openaire   +2 more sources

Low IgG antibody production in the elderly Japanese population after full BNT162b2 vaccination

Journal of Hospital General Medicine, 2023
[Background] Several vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are in use worldwide. However, their efficacy and safety in the elderly have not been fully assessed.
Hiroaki Ikezaki, Yuichi Hara, Jun Hayashi, Hiroshi Hara, Hideyuki Nomura, Nobuyuki Shimono   +5 more
doaj   +1 more source